Dr. Yaddanapudi Ravindranath, MBBS
Dr Ravindranath (Dr Ravi) currently is a Professor of Pediatrics, at Wayne State University School of Medicine, Detroit, Michigan, USA. Dr Ravi, hails from Warangal (Telangana) India, obtained his medical degree from Gandhi Medical School, Osmania University, Hyderabad, India (1964); Pediatric Hematology/Oncology training was at Children’s Hospital of Michigan, Detroit, MI 1(969-71). Dr Ravi is most known for his work in childhood leukemias and for development of collaborative programs for improving care of children with cancer in India, South America and the Middle East. In April 2009, he was admitted to the Wayne State University Academy of Scholars. In 2023, ChatGPT listed Dr Ravi among the top ten Prominent Pediatric Hematologists worldwide.
Notable scientific achievements include- first descriptions of identification of T-Cell leukemia and immunophenotyping of leukemias (1975,1977, 2008),:identification of the high curability of the myeloid leukemia in children with Down Syndrome (1992, 2003, 2008). Aside from the above work in oncology, there are several important contributions in red cell disorders as well- novel variants of Glycolytic enzymes (GPI, PKLR, PGK1) and G6PD.
Dr Ravi and colleagues were among the first to develop (1993) develop chemoreduction strategy in the treatment of retinoblastoma, aimed at eye preservation and avoiding external beam radiation; in 1995 he transported this modality of therapy to India and Egypt. Dr Ravi was an integral member of the SIOP team that initiated the development of InPOG ( Indian Pediatric Oncology Group)
Publications as of July 2026: 195 full manuscripts, 35 brief communications ( case reports, letters commentaries) , 20 book chapters; 235 Presentations. H Index 51
ORCID-ID: 0000-0001-9577-9624
